Calocurb, the New Zealand-based company bringing the world the first 100% natural GLP-1 activator, recently announced the publication of a new clinical study in US medical journal, Obesity Pillars, demonstrating Calocurbs effectiveness in weight loss and muscle preservation
Abnormal insulin secretion in Parkinsons disease before and during L-dihydroxyphenylalanine (L-dopa) therapy
Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate
By boosting this enzyme and supplementing glutathione levels we can increase glutathione levels and glutathione recycling to reduce inflammation in the body and possibly prevent it from occurring in the first instance
NHS provision of tirzepatide for weight management requires referral to a specialist weight management service and meeting specific BMI criteria (typically 35 kg/m or 30 kg/m with weight-related comorbidities)